Literature DB >> 29217870

Temporal Prediction of Future State Occupation in a Multistate Model from High-Dimensional Baseline Covariates via Pseudo-Value Regression.

Sandipan Dutta1, Susmita Datta2, Somnath Datta2.   

Abstract

In many complex diseases such as cancer, a patient undergoes various disease stages before reaching a terminal state (say disease free or death). This fits a multistate model framework where a prognosis may be equivalent to predicting the state occupation at a future time t. With the advent of high throughput genomic and proteomic assays, a clinician may intent to use such high dimensional covariates in making better prediction of state occupation. In this article, we offer a practical solution to this problem by combining a useful technique, called pseudo value regression, with a latent factor or a penalized regression method such as the partial least squares (PLS) or the least absolute shrinkage and selection operator (LASSO), or their variants. We explore the predictive performances of these combinations in various high dimensional settings via extensive simulation studies. Overall, this strategy works fairly well provided the models are tuned properly. Overall, the PLS turns out to be slightly better than LASSO in most settings investigated by us, for the purpose of temporal prediction of future state occupation. We illustrate the utility of these pseudo-value based high dimensional regression methods using a lung cancer data set where we use the patients' baseline gene expression values.

Entities:  

Keywords:  Censoring; Covariate; Gene expression; LASSO; PLS; Survival

Year:  2016        PMID: 29217870      PMCID: PMC5714309          DOI: 10.1080/00949655.2016.1263992

Source DB:  PubMed          Journal:  J Stat Comput Simul        ISSN: 0094-9655            Impact factor:   1.424


  9 in total

1.  Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function.

Authors:  John P Klein; Per Kragh Andersen
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

2.  Regression analysis of restricted mean survival time based on pseudo-observations.

Authors:  Per Kragh Andersen; Mette Gerster Hansen; John P Klein
Journal:  Lifetime Data Anal       Date:  2004-12       Impact factor: 1.588

3.  Analyzing survival curves at a fixed point in time.

Authors:  John P Klein; Brent Logan; Mette Harhoff; Per Kragh Andersen
Journal:  Stat Med       Date:  2007-10-30       Impact factor: 2.373

4.  On pseudo-values for regression analysis in competing risks models.

Authors:  Frederik Graw; Thomas A Gerds; Martin Schumacher
Journal:  Lifetime Data Anal       Date:  2008-12-03       Impact factor: 1.588

5.  The lasso method for variable selection in the Cox model.

Authors:  R Tibshirani
Journal:  Stat Med       Date:  1997-02-28       Impact factor: 2.373

6.  Pseudo-observations for competing risks with covariate dependent censoring.

Authors:  Nadine Binder; Thomas A Gerds; Per Kragh Andersen
Journal:  Lifetime Data Anal       Date:  2013-02-22       Impact factor: 1.588

7.  A random forest approach for competing risks based on pseudo-values.

Authors:  Ulla B Mogensen; Thomas A Gerds
Journal:  Stat Med       Date:  2013-03-18       Impact factor: 2.373

8.  Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Authors:  David G Beer; Sharon L R Kardia; Chiang-Ching Huang; Thomas J Giordano; Albert M Levin; David E Misek; Lin Lin; Guoan Chen; Tarek G Gharib; Dafydd G Thomas; Michelle L Lizyness; Rork Kuick; Satoru Hayasaka; Jeremy M G Taylor; Mark D Iannettoni; Mark B Orringer; Samir Hanash
Journal:  Nat Med       Date:  2002-07-15       Impact factor: 53.440

9.  Sparse partial least squares regression for simultaneous dimension reduction and variable selection.

Authors:  Hyonho Chun; Sündüz Keleş
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2010-01       Impact factor: 4.488

  9 in total
  1 in total

1.  A semiparametric modeling approach for analyzing clinical biomarkers restricted to limits of detection.

Authors:  Sandipan Dutta; Susan Halabi
Journal:  Pharm Stat       Date:  2021-04-14       Impact factor: 1.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.